Will Amgen Stock Continue To See Higher Levels Driven By Its Obesity Injection?
9/5 02:40
Amgen stock (NASDAQ: AMGN) has seen a solid 9% rise in a week, outperforming the broader S&P500 index, up 1.5%. The recent rise can be attributed to the progress with its weight-loss drug — MariTide and its upbeat Q1 results reported last week. The company reported reve...